{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:10:07Z","timestamp":1793419807770,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaad.2014.05.036","type":"journal-article","created":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T21:39:39Z","timestamp":1404250779000},"page":"973-980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["The psychological impact of rosacea and the influence of current management options"],"prefix":"10.1016","volume":"71","author":[{"given":"Farah","family":"Moustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin S.","family":"Lewallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.05.036_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.2044-8341.1951.tb00404.x","article-title":"A Rorschach study of rosacea and morbid blushing","volume":"24","author":"Plesch","year":"1951","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.jaad.2014.05.036_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.1961.tb14422.x","article-title":"Psychosomatic aspects of rosacea","volume":"73","author":"Whitlock","year":"1961","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2014.05.036_bib3","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/S0151-9638(11)70086-2","article-title":"The red face: art, history and medical representations","volume":"138","author":"Cribier","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.05.036_bib4","first-page":"435","article-title":"Rosacea: a common, yet commonly overlooked, condition","volume":"66","author":"Blount","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2014.05.036_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society expert committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2011.10473.x","article-title":"Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review","volume":"165","author":"van Zuuren","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2133.2012.11148.x","article-title":"Lack of \u2018appropriately assessed\u2019 patient-reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea","volume":"168","author":"van Zuuren","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaad.2009.08.020","article-title":"A pilot study in discrepancies in quality of life among three cutaneous types of rosacea","volume":"62","author":"Kini","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib9","first-page":"385","article-title":"Quality of life in patients with rosacea [in Polish]","volume":"65","author":"Salamon","year":"2008","journal-title":"Przegl Lek"},{"key":"10.1016\/j.jaad.2014.05.036_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000330555","article-title":"Quality of health care of rosacea in Germany from the patient's perspective: results of the national health care study Rosareal 2009","volume":"223","author":"Langenbruch","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2014.05.036_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2001-19630","article-title":"Quality of life in patients with rosacea and rhinophyma","volume":"27","author":"Hiltscher","year":"2001","journal-title":"[German]. Akt Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib12","doi-asserted-by":"crossref","unstructured":"Bohm D, Schwanitz P, Stock GS, Schmid-Ott G, Schulz W. Symptom severity and psychological sequelae in rosacea: results of a survey. Psychol Health Med doi:10.1080\/13548506.2013.841968. Published online October 3, 2013.","DOI":"10.1080\/13548506.2013.841968"},{"key":"10.1016\/j.jaad.2014.05.036_bib13","first-page":"30","article-title":"The effect of pulsed dye laser on the Dermatology Life Quality Index in erythematotelangiectatic rosacea patients: an assessment","volume":"6","author":"Shim","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14764170902741311","article-title":"Quality of life and rosacea: pulsed dye laser impact","volume":"11","author":"Menezes","year":"2009","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.jaad.2014.05.036_bib15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaad.2004.04.010","article-title":"Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life","volume":"51","author":"Tan","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","article-title":"The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities","volume":"163","author":"Aksoy","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib17","first-page":"299","article-title":"Treatment of papulopustular rosacea with sodium sulfacetamide 10%\/sulfur 5% emollient foam","volume":"8","author":"Trumbore","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib18","first-page":"585","article-title":"The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life","volume":"4","author":"Fleischer","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2014.05.036_bib19","first-page":"26","article-title":"A community-based study of the effectiveness of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) on quality of life and satisfaction with treatment in participants with rosacea","volume":"86","author":"Baldwin","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2014.05.036_bib20","first-page":"316","article-title":"Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies","volume":"13","author":"Stein","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaad.2014.05.036_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000339478","article-title":"Evaluation of quality of life after a medical corrective make-up lesson in patients with various dermatoses","volume":"224","author":"Peuvrel","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2014.05.036_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-4632.2011.05353.x","article-title":"Randomized, double-blind trial of 220 mg zinc sulfate twice\u00a0daily in the treatment of rosacea","volume":"51","author":"Bamford","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1468-3083.2012.04549.x","article-title":"Willingness to pay and quality of life in patients with rosacea","volume":"27","author":"Beikert","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.05.036_bib26","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-2133.2005.06895.x","article-title":"Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey\u2013Outpatient Department data collected by the US National Center for Health Statistics from 1995 to 2002","volume":"153","author":"Gupta","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib27","first-page":"997","article-title":"Psychosocial impact of rosacea [in Polish]","volume":"64","author":"Chodkiewicz","year":"2007","journal-title":"Przegl Lek"},{"key":"10.1016\/j.jaad.2014.05.036_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00403-011-1177-1","article-title":"Endothelial and axon reflex vasodilatation to acetylcholine in rosacea-affected skin","volume":"304","author":"Drummond","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2014.05.036_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/cpp.763","article-title":"Blushing propensity and psychological distress in people with rosacea","volume":"19","author":"Su","year":"2012","journal-title":"Clin Psychol Psychother"},{"key":"10.1016\/j.jaad.2014.05.036_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2340\/00015555-0716","article-title":"Subjective disease perception and symptoms of depression in relation to healthcare-seeking behavior in patients with rosacea","volume":"89","author":"Abram","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2014.05.036_bib31","first-page":"97","article-title":"Standard management options for rosacea, part 2: options according to subtype","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2014.05.036_bib32","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","article-title":"Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline","volume":"143","author":"Shanler","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10103-002-8263-8","article-title":"Laser treatment of erythema and telangiectasia associated with rosacea","volume":"17","author":"Clark","year":"2002","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jaad.2014.05.036_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jpsychores.2011.09.002","article-title":"Blushing in rosacea sufferers","volume":"72","author":"Drummond","year":"2012","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jaad.2014.05.036_bib35","first-page":"650","article-title":"Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies","volume":"12","author":"Fowler","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.05.036_bib36","unstructured":"Galderma. Mirvaso: demonstrated tolerability. Available from: URL:http:\/\/mirvaso.com\/hcp\/tolerability. Accessed March 30, 2014."},{"key":"10.1016\/j.jaad.2014.05.036_bib37","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jaad.2013.10.054","article-title":"Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%","volume":"70","author":"Routt","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214015230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214015230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:32:46Z","timestamp":1759271566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214015230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0190962214015230"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.05.036","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The psychological impact of rosacea and the influence of current management options","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}